Matches in Wikidata for { <http://www.wikidata.org/entity/Q57396239> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- Q57396239 description "article scientifique publié en 2011" @default.
- Q57396239 description "article" @default.
- Q57396239 description "im Oktober 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57396239 description "wetenschappelijk artikel" @default.
- Q57396239 description "наукова стаття, опублікована в жовтні 2011" @default.
- Q57396239 name "Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)" @default.
- Q57396239 name "Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)" @default.
- Q57396239 type Item @default.
- Q57396239 label "Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)" @default.
- Q57396239 label "Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)" @default.
- Q57396239 prefLabel "Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)" @default.
- Q57396239 prefLabel "Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)" @default.
- Q57396239 P1433 Q57396239-AEF4C6D3-9028-4D70-84BB-C9A3214F53DE @default.
- Q57396239 P1476 Q57396239-EAD86549-85E4-4461-89E6-0FBE6FC67EA4 @default.
- Q57396239 P2093 Q57396239-080E90FF-51F1-4009-B490-4CE13713327C @default.
- Q57396239 P2093 Q57396239-2BF19EDE-0E66-47D6-92FA-BDD929644CB5 @default.
- Q57396239 P2093 Q57396239-3688FF3D-A6B8-4AA3-9AC4-81779C39283B @default.
- Q57396239 P2093 Q57396239-8E55686A-32FD-4393-A0B8-9DFA22CDC585 @default.
- Q57396239 P2093 Q57396239-B8995D4A-73AF-473A-918A-E506C05B5DB0 @default.
- Q57396239 P304 Q57396239-A55A2B80-DE57-4595-B3E4-2C6E33CCF871 @default.
- Q57396239 P31 Q57396239-37B12F5E-2F67-4011-8138-F9B03B3F444F @default.
- Q57396239 P356 Q57396239-C626254D-5256-45B6-8B10-92512B812BF7 @default.
- Q57396239 P407 Q57396239-BDBCFED9-1F81-43BF-90BB-D5478A04A194 @default.
- Q57396239 P433 Q57396239-656EF8F0-D7C6-46F7-B182-D607A5DE0F32 @default.
- Q57396239 P478 Q57396239-6704AF12-DC02-4951-9578-6BB28DE2EE30 @default.
- Q57396239 P50 Q57396239-2C2ED5D0-7854-44CB-84B8-AAA34AADA121 @default.
- Q57396239 P50 Q57396239-5CE8A74B-176D-40D4-83E2-AEB0BD07E388 @default.
- Q57396239 P50 Q57396239-61AD00FC-59A0-49B9-9450-BA9EC5E1CFC8 @default.
- Q57396239 P50 Q57396239-69289B1C-FCB4-4047-9213-85DEADF2E292 @default.
- Q57396239 P50 Q57396239-828A8668-5897-41E8-B8F0-6DD58A387FB2 @default.
- Q57396239 P50 Q57396239-A70904AD-2029-45D8-B5B7-DCB4F82D18AF @default.
- Q57396239 P50 Q57396239-C797E12E-AC60-446F-98AE-51DA495553AB @default.
- Q57396239 P50 Q57396239-D6F84CBB-53A1-4633-B5B4-8A0F0743B9D1 @default.
- Q57396239 P50 Q57396239-EDE12302-FF6D-41D3-B22C-C5C799FCE317 @default.
- Q57396239 P50 Q57396239-F2ED23D6-EE81-4911-83CF-182B6D1DDEB3 @default.
- Q57396239 P577 Q57396239-B17E9499-0395-4E5F-8FFF-539512516790 @default.
- Q57396239 P698 Q57396239-12CB9F56-918E-43D9-BF7B-9E2CBB1F6548 @default.
- Q57396239 P921 Q57396239-41A67EA3-F019-458A-B429-E5129A80F4A9 @default.
- Q57396239 P921 Q57396239-743E864C-1926-4673-A53C-455B68E2F460 @default.
- Q57396239 P921 Q57396239-960B1D52-B381-45F1-93EB-8D3161128639 @default.
- Q57396239 P921 Q57396239-98E99D21-C9A9-40EB-AC16-940620E947F0 @default.
- Q57396239 P921 Q57396239-DBC5BEDC-633F-44D1-A56E-1603D81AAEF7 @default.
- Q57396239 P356 J.AHJ.2011.07.016 @default.
- Q57396239 P698 21982669 @default.
- Q57396239 P1433 Q2227156 @default.
- Q57396239 P1476 "Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)" @default.
- Q57396239 P2093 "Akshay S. Desai" @default.
- Q57396239 P2093 "Dick de Zeeuw" @default.
- Q57396239 P2093 "Peter Ivanovich" @default.
- Q57396239 P2093 "Petr Jarolim" @default.
- Q57396239 P2093 "Scott D. Solomon" @default.
- Q57396239 P304 "748-755.e3" @default.
- Q57396239 P31 Q13442814 @default.
- Q57396239 P356 "10.1016/J.AHJ.2011.07.016" @default.
- Q57396239 P407 Q1860 @default.
- Q57396239 P433 "4" @default.
- Q57396239 P478 "162" @default.
- Q57396239 P50 Q104110852 @default.
- Q57396239 P50 Q114321706 @default.
- Q57396239 P50 Q114321755 @default.
- Q57396239 P50 Q114398840 @default.
- Q57396239 P50 Q56633150 @default.
- Q57396239 P50 Q77053619 @default.
- Q57396239 P50 Q88093404 @default.
- Q57396239 P50 Q90134887 @default.
- Q57396239 P50 Q91630122 @default.
- Q57396239 P50 Q92434434 @default.
- Q57396239 P577 "2011-10-01T00:00:00Z" @default.
- Q57396239 P698 "21982669" @default.
- Q57396239 P921 Q11068 @default.
- Q57396239 P921 Q181600 @default.
- Q57396239 P921 Q2178381 @default.
- Q57396239 P921 Q3025883 @default.
- Q57396239 P921 Q736715 @default.